product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Livin (D61D1) XP® Rabbit mAb
catalog :
5471
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
D61D1
reactivity :
human
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation
more info or order :
citations: 6
Published Application/Species/Sample/Dilution | Reference |
---|---|
| |
| Wang J, Ma L, Tang X, Zhang X, Qiao Y, Shi Y, et al. Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells. Oncotarget. 2015;6:24075-91 pubmed
|
| |
| |
| |
product information
SKU :
5471P
Product-Name :
Livin (D61D1) XP® Rabbit mAb
Size :
40 ul
Price-(USD) :
135 USD
Species-x-Reactivity :
H
Applications :
Immunofluorescence (Immunocytochemistry)
Product-Category :
Apoptosis
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
34, 36
Host :
Rabbit
Target :
Livin
Primary-Protein :
BIRC7
Alt-Names :
BIRC7,Baculoviral IAP repeat-containing protein 7,KIAP,Kidney inhibitor of apoptosis protein,LIVIN,ML-IAP,MLIAP,Melanoma inhibitor of apoptosis protein,RING finger protein 50,RNF50,baculoviral IAP repeat-containing 7,livin inhibitor of apoptosis,livin inhibitor-of-apoptosis
more info or order :
company information
Cell Signaling Technology
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.
review
product type
browse more products
questions and comments